Connect with us

Health

Nigerians Won’t Feel Exit of GSK, Sanofi, Others—Local Drug Makers

Published

on

GlaxoSmithKline GSK

By Adedapo Adesanya

The Pharmaceutical Manufacturers Group under the Manufacturers’ Association of Nigeria (MAN) has called on its members to leverage the exit of foreign pharmaceutical companies to boost medicine production.

Recall that pharmaceutical companies, including GlaxoSmithKline and Sanofi Nigeria Limited, exited the country due to challenges with foreign exchange, ease of doing business, multiple taxation, and importation bureaucracy, among others.

In an interview with the News Agency of Nigeria (NAN) on Saturday in Lagos, Mr Oluwatosin Jolayemi, Chairman of the sub-group and Managing Director of Daily-Need Industries Limited, said the industry was ready to step up to ensure that Nigerians don’t feel the exit.

He disclosed that between six and 11 pharmaceutical factories were poised to produce products that GSK, Sanofi and other pharmaceutical companies had produced.

“Maybe there are some SKUs (Store Keeping Units) that we do not have the capacity for. The ones that we have the capacity for, which is the bulk of what they bring into the country, we are ready for.

“But the issue is that medicine is not just like sewing clothes or buying shoes. There is a process to manufacture medicine.

“But we are ready in the industry because we have between 6 and 11 factories that are poised to produce those products that GSK, Sanofi and others have. And because most of these products are generic, we are poised to produce them,” he said.

He emphasised that the government must have a policy statement and be deliberate to ensure local pharmaceutical companies fill the gaps and thrive through an enabling environment and business-friendly regulation.

“Either the government or NAFDAC has to be able to take advantage and let the local industry take advantage of the lacuna.

“And give priorities so that the prices of drugs, particularly these antibiotics could come down.

“But, as long as we are still holding on to the bottlenecks, the problem continues to linger, and the cost of medicines remains high,” he said.

He noted that the government must ensure that a lot of bottlenecks should be addressed, citing issues with regulation and the process of registration.

“We are not asking for the standard to be dropped. We are just asking that we should work together in the interest of the populace and see how we can begin to make these products available.

“Because these products are generic. They are not rocket science. They are not new molecules. They are old molecules that have been on the market for 20 to 30 years.

“So, this is something that we could always workaround, but it is left to the government and NAFDAC to decide,” he said.

Speaking on the rising cost of medicine, Mr Jolayemi attributed it to fluctuating foreign exchange rates, indiscriminate custom tariff regimes, high cost of electricity tariffs and operating costs, among others.

He stressed that it was cheaper to produce locally, noting that active pharmaceutical ingredients (APIs) and excipients are mostly imported by manufacturers.

Mr Jolayemi disclosed that a German company and another consortium are currently investing in API manufacturing.

“They are doing the formal analysis. And we hope that if those ones come on board, they cannot supply all the APIs that are required in the industry.

“But at least they will be able to take care of the usual regular ones that are common to use in the industry,” he said.

Mr Jolayemi also urged the federal government to assist manufacturers with soft loans and grants to boost production as done by the governments of India and China.

“The government needs to encourage pharmaceutical companies because APIs and medicine are national issues.

“The government needs to see healthcare as a national policy and begin to take it like that because if you have hospitals, no matter how beautiful your hospitals are, if there are no medicines, the hospital just becomes a consulting unit,” he said.

He emphasised that the government must prioritise healthcare, especially medicine production, availability and affordability for its citizens.

Adedapo Adesanya is a journalist, polymath, and connoisseur of everything art. When he is not writing, he has his nose buried in one of the many books or articles he has bookmarked or simply listening to good music with a bottle of beer or wine. He supports the greatest club in the world, Manchester United F.C.

Health

Nigeria Launch €4.2m Initiative to Boost Capacity Against Outbreaks

Published

on

health financing fg

By Adedapo Adesanya

Nigeria has launched a €4.2 million programme supported by the European Union (EU) and implemented by the World Health Organisation (WHO) to strengthen the country’s capacity to detect and respond to disease outbreaks.

The initiative, known as the EU Support to Public Health Institutes in Nigeria (EU SPIN), will be carried out over four years in partnership with the Federal Ministry of Health and Social Welfare.

It is aimed at improving the performance of selected public health institutions through better coordination, faster information sharing and enhanced workforce capacity.

Speaking at the launch in Abuja on Monday, the Minister of State for Health and Social Welfare, Mr Iziaq Adekunle Salako, described the programme as a significant step towards strengthening Nigeria’s healthcare system.

“This initiative is designed to strengthen our health institutions, and it is truly a welcome development. It will improve the well-being of Nigerians, especially our vulnerable populations,” he said, noting that it aligns with the federal government’s broader health reform agenda.

Nigeria continues to face a dual health burden, with recurring infectious disease outbreaks alongside a growing prevalence of non-communicable diseases such as hypertension and diabetes.

According to the WHO, non-communicable diseases now account for 27 per cent of deaths in the country, while malaria alone contributes about 30 per cent of global malaria fatalities.

Recurrent outbreaks of cholera, diphtheria, Lassa fever, meningitis and Mpox also remain a major public health concern.

The EU SPIN programme is expected to address systemic gaps that slow outbreak response by strengthening collaboration among public health institutions and clarifying roles across federal, state and local levels.

It will also support real-time data systems to enable quicker and more informed decision-making during health emergencies.

A key component of the initiative is workforce development, with plans to train up to 75 per cent of public health staff in leadership, prevention and response strategies, as well as digital skills.

The European Union Ambassador to Nigeria, Mr Gautier Mignon, said the programme reflects a shared commitment to building resilient health systems.

“Through EU SPIN, the European Union is investing in strong, digitally enabled public health institutions in Nigeria. This partnership underscores our commitment to health security and sustainable systems strengthening,” he said.

Also speaking, the WHO Representative in Nigeria, Mr Pavel Ursu, noted that improved coordination and digital tools would enhance the country’s ability to protect lives.

“By improving coordination, skills and digital tools, the project will help protect lives and keep communities healthier,” he said.

Officials said the programme would ultimately strengthen links between public health systems and primary healthcare services, ensuring that communities benefit from faster and more effective responses to health threats.

By 2028, the initiative is expected to deliver more efficient inter-agency coordination, clearer institutional responsibilities and more reliable public health data nationwide, with progress tracked through national monitoring systems and periodic reviews involving government and development partners.

Continue Reading

Health

Malaria: SUNU Health Advocates Wider Adoption of HMO Plans

Published

on

SUNU Health --logo

By Aduragbemi Omiyale

To achieve a malaria-free Nigeria, a leading Health Maintenance Organisation (HMO) with a robust nationwide presence, SUNU Health Nigeria Limited, has called for a wider adoption of HMO packages for citizens.

It stressed that managed care provides a critical safety net, ensuring families can access quality preventive services without the burden of immediate, high costs, adding that this structured approach transforms healthcare from an unpredictable expense into a manageable, guaranteed service.

The company, which officially unveiled a comprehensive strategic roadmap aimed at drastically cutting down on malaria-related deaths, emphasised that the disease can be eradicated if citizens and stakeholders adopt consistent preventive measures.

“Eradication is within our reach if we synchronise our efforts,” the chief operating officer of SUNU Health, Dr Faith Nwachi, said, noting that the tools for victory range from environmental hygiene to the consistent use of treated nets, which are easily accessible to every Nigerian.

The organisation noted that it came up with the latest framework to significantly reduce the disease burden that has historically hindered Nigeria’s productivity and public health stability.

The urgency of this intervention is underscored by concerning data from late 2025, which revealed a sharp upward trend in cases, it stated.

With over 24.5 million confirmed cases reported in the first nine months of last year alone, the 2026 landscape demands aggressive action. Currently, malaria remains a leading cause of mortality, responsible for approximately 30 per cent of child deaths and 11 per cent of maternal deaths annually.

A central pillar of the roadmap is a focus on preventative care. As of early 2026, according to the World Health Organisation, malaria still accounts for nearly 30 per cent of all hospital admissions in Nigeria.

By addressing the root causes and transmission cycles, SUNU Health seeks to drastically lower these statistics, ensuring Nigerians can lead more active lives without the constant threat of infection.

Dr Nwachi further underscored the economic necessity of this shift, stating that “prevention is significantly cheaper than cure.”

The financial toll on the Nigerian economy is staggering, with billions of Naira lost annually to treatments and diminished man-hours. For the average family, frequent bouts of illness lead to catastrophic out-of-pocket expenses that undermine financial security.

Continue Reading

Health

AltBank, Partners Recommend Autism Care Financing Options, Others to Government

Published

on

Autism Care Financing Options

By Aduragbemi Omiyale

Plans are underway by the Alternative Bank (AltBank) to present a policy brief to relevant government ministries, recommending vocational pathways, autism care financing options, and a 12-month Lagos pilot across selected schools and primary healthcare centres.

The recommendations are from the inaugural Autism Stakeholders Roundtable and Policy Dialogue in Lagos, organised by the lender in partnership with the Private Sector Health Alliance of Nigeria (PSHAN), Eliakim Foundation, and Sterling One Foundation under the theme, It is How You Show Up.

The programme served as a critical platform to address the country’s fragmented autism support systems, with leading healthcare professionals, policymakers, and autism advocates in attendance, praising the financial institution’s decisive shift toward early intervention, systemic inclusion, and comprehensive capacity building for parents and caregivers.

The president of the Medical Women’s Association of Nigeria (MWAN) Lagos State Branch, Dr Ime Okon, stressed her group’s alignment with the bank’s initiatives.

“We recognise caregivers and families as central to the success of any intervention. We are showing up, holding their hands, to ensure they are never left to navigate this journey alone.

“For a physician, showing up means ensuring that a parent’s first concern is met with a strengthened, inclusive system rather than a clinical dead-end with no solution. The Alternative Bank has signalled a shift toward a high-level platform for national action,” she stated.

Validating this urgent need for systemic early response, the keynote speaker and founder of the Patrick Speech and Languages Centre (PSLC), Mrs Dotun Akande, advocated the integration of universal developmental screening into primary healthcare, stressing that Nigeria must transition from relying on parallel private centres to building a coordinated national response.

“What Nigeria must now build is a system where intervention happens early, equitably, and at scale, without depending on chance, geography, or privilege,” Mrs Akande noted, outlining the necessity of a caregiver support scheme that addresses both the financial and social needs of families navigating autism.

Answering this call to action, the Executive Director of Commercial and Institutional Banking (Lagos and Southwest) at The Alternative Bank, Mrs Korede Demola-Adeniyi, unveiled the financial institution’s concrete commitments to parent and professional training.

Noting that showing up in Nigeria has “too often meant showing up late,” she announced a robust three-pillar intervention agenda focusing on inclusive education, targeted training for caregivers and health professionals, and behavioural change advocacy.

As an immediate first step, Mrs Demola-Adeniyi announced the launch of a specialised capacity-building programme on Receptive Language Disorder, executed in collaboration with Eliakim Global Resources, which commenced on Sunday, April 26, 2026.

“Early recognition and sustained support depend on a workforce and caregivers who know what to look for, and what to do next,” she explained, emphasising that receptive language is a consequential developmental marker that is frequently missed.

The roundtable fostered dynamic discussions on practically designing and sustainably funding high-impact support programmes.

Continue Reading

Trending